Novartis A G Sponsored Adr (NVS) Holder Assetmark Has Trimmed Holding; As Makemytrip Limited Mauritius (MMYT) Share Value Rose, Ward Ferry Management LTD Upped by $9.04 Million Its Stake

January 9, 2018 - By Linda Rogers

Ward Ferry Management Ltd increased its stake in Makemytrip Limited Mauritius (MMYT) by 13.38% based on its latest 2017Q3 regulatory filing with the SEC. Ward Ferry Management Ltd bought 322,700 shares as the company’s stock rose 2.51% with the market. The institutional investor held 2.74 million shares of the transportation services company at the end of 2017Q3, valued at $78.64M, up from 2.41 million at the end of the previous reported quarter. Ward Ferry Management Ltd who had been investing in Makemytrip Limited Mauritius for a number of months, seems to be bullish on the $3.19 billion market cap company. The stock increased 2.94% or $0.9 during the last trading session, reaching $31.55. About 225,577 shares traded. MakeMyTrip Limited (NASDAQ:MMYT) has risen 111.67% since January 9, 2017 and is uptrending. It has outperformed by 94.97% the S&P500.

Assetmark Inc decreased its stake in Novartis A G Sponsored Adr (NVS) by 97.87% based on its latest 2017Q3 regulatory filing with the SEC. Assetmark Inc sold 91,775 shares as the company’s stock rose 4.17% with the market. The institutional investor held 2,002 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $172,000, down from 93,777 at the end of the previous reported quarter. Assetmark Inc who had been investing in Novartis A G Sponsored Adr for a number of months, seems to be less bullish one the $203.07 billion market cap company. The stock decreased 0.06% or $0.05 during the last trading session, reaching $86.22. About 1.08 million shares traded. Novartis AG (NYSE:NVS) has risen 7.67% since January 9, 2017 and is uptrending. It has underperformed by 9.03% the S&P500.

Assetmark Inc, which manages about $13.57 billion and $8.79 billion US Long portfolio, upped its stake in Philip Morris Intl Inc Com (NYSE:PM) by 30,585 shares to 191,009 shares, valued at $21.20M in 2017Q3, according to the filing. It also increased its holding in Monsanto Co New Com (NYSE:MON) by 34,349 shares in the quarter, for a total of 34,937 shares, and has risen its stake in Taiwan Semiconductor Mfg Ltd Sponsored Adr (NYSE:TSM).

Among 16 analysts covering Novartis Ag (NYSE:NVS), 5 have Buy rating, 4 Sell and 7 Hold. Therefore 31% are positive. Novartis Ag had 34 analyst reports since July 28, 2015 according to SRatingsIntel. On Tuesday, January 3 the stock rating was downgraded by JP Morgan to “Neutral”. The rating was upgraded by Argus Research to “Buy” on Thursday, November 10. On Thursday, June 22 the stock rating was maintained by Leerink Swann with “Hold”. The stock has “Underperform” rating by Mainfirst on Wednesday, October 28. The rating was downgraded by Morgan Stanley on Tuesday, April 12 to “Underperform”. Societe Generale upgraded Novartis AG (NYSE:NVS) on Wednesday, March 8 to “Buy” rating. The stock of Novartis AG (NYSE:NVS) has “Market Perform” rating given on Wednesday, April 5 by Cowen & Co. UBS downgraded the shares of NVS in report on Friday, April 1 to “Neutral” rating. Goldman Sachs maintained the stock with “Neutral” rating in Thursday, March 23 report. The stock of Novartis AG (NYSE:NVS) has “Hold” rating given on Tuesday, July 18 by Cowen & Co.

Analysts await Novartis AG (NYSE:NVS) to report earnings on January, 24. They expect $1.16 EPS, up 3.57% or $0.04 from last year’s $1.12 per share. NVS’s profit will be $2.73 billion for 18.58 P/E if the $1.16 EPS becomes a reality. After $1.29 actual EPS reported by Novartis AG for the previous quarter, Wall Street now forecasts -10.08% negative EPS growth.